This article like a handy guide can help you choose the right product for you that your physician can integrate into your ...

The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...

PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded ...

The FDA declared the end to shortages of Zepbound and Mounjaro. That could mean new restrictions on pharmacies making ...

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making ...

Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, ...

Shares in Hims & Hers Health fell after the U.S. Food and Drug Administration said Eli Lilly's obesity and diabetes drugs are no longer in shortage. Shares were down 7% in premarket trading to $17.64.

Eli Lilly's blockbuster weight-loss drug is no longer in shortage in the United States, the U.S. Food and Drug Administration ...

Mounjaro has been on the FDA's shortage list since late 2022, while Zepbound was added to the list in April this year.

The best diets are healthy eating patterns that emphasize whole, nutrient-rich plant foods and minimize heavily processed ...

These snacks have a good mix of carbs, protein, fat and fiber for an energy boost that won’t send your blood sugars out of ...

These are the most unhealthy fast-food hamburgers in the U.S. ranked, according to a study. Nutritionists explain the ...